Anavex Life Sciences Corp (AVXL) returns
Anavex Life Sciences returns over 10 years
$1,000 invested in Anavex Life Sciences ten years ago was worth $402.03 at the close on October 30, 2026, with dividends reinvested: an average return of -8.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -41.1% | — | $589.11 | -0.9% |
| 3 months | -55.9% | — | $440.74 | +2.1% |
| Year to date | -66.6% | — | $334.27 | +11.7% |
| 1 year | -85.2% | — | $148.19 | +12.4% |
| 3 years | -78.4% | -40.0% | $216.36 | +88.5% |
| 5 years | -93.6% | -42.4% | $63.50 | +76.0% |
| 10 years | -59.8% | -8.7% | $402.03 | +316.6% |
Anavex Life Sciences return by calendar year
| Year | AVXL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -66.6% | +11.7% | -78.3% |
| 2025 | -66.9% | +17.7% | -84.6% |
| 2024 | +15.4% | +24.9% | -9.5% |
| 2023 | +0.5% | +26.2% | -25.6% |
| 2022 | -46.6% | -18.2% | -28.4% |
| 2021 | +221.1% | +28.7% | +192.4% |
| 2020 | +108.5% | +18.4% | +90.1% |
| 2019 | +66.0% | +31.2% | +34.8% |
| 2018 | -51.6% | -4.6% | -47.0% |
| 2017 | -18.7% | +21.7% | -40.4% |
| 2016 | -28.9% | +12.0% | -40.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Anavex Life Sciences Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.